A person’s risk of progressing from a benign condition called monoclonal gammopathy of undetermined significance (MGUS) to the blood cancer multiple myeloma can change over time, according to a new study.
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/2Z3i1Eb
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/2Z3i1Eb